X-ray luminescence computed tomography using a focused X-ray beam

Due to the low X-ray photon utilization efficiency and low measurement sensitivity of the electron multiplying charge coupled device (EMCCD) camera setup, the collimator based narrow beam X-ray luminescence computed tomography (XLCT) usually requires a long measurement time. In this paper, we, for the first time, report a focused X-ray beam based XLCT imaging system with measurements by a single optical fiber bundle and a photomultiplier tube (PMT). An X-ray tube with a polycapillary lens was used to generate a focused X-ray beam whose X-ray photon density is 1200 times larger than a collimated X-ray beam. An optical fiber bundle was employed to collect and deliver the emitted photons on the phantom surface to the PMT. The total measurement time was reduced to 12.5 minutes. For numerical simulations of both single and six fiber bundle cases, we were able to reconstruct six targets successfully. For the phantom experiment, two targets with an edge-to-edge distance of 0.4 mm and a center-to-center distance of 0.8 mm were successfully reconstructed by the measurement setup with a single fiber bundle and a PMT.Comment: 39 Pages, 12 Figures, 2 Tables, In submission (under review) to JB

Imaging dose from cone beam computed tomography in radiation therapy

AbstractImaging dose in radiation therapy has traditionally been ignored due to its low magnitude and frequency in comparison to therapeutic dose used to treat patients. The advent of modern, volumetric, imaging modalities, often as an integral part of linear accelerators, has facilitated the implementation of image-guided radiation therapy (IGRT), which is often accomplished by daily imaging of patients. Daily imaging results in additional dose delivered to patient that warrants new attention be given to imaging dose. This review summarizes the imaging dose delivered to patients as the result of cone beam computed tomography (CBCT) imaging performed in radiation therapy using current methods and equipment. This review also summarizes methods to calculate the imaging dose, including the use of Monte Carlo (MC) and treatment planning systems (TPS). Peripheral dose from CBCT imaging, dose reduction methods, the use of effective dose in describing imaging dose, and the measurement of CT dose index (CTDI) in CBCT systems are also reviewed

Multi-Beam Scan Analysis with a Clinical LINAC for High Resolution Cherenkov-Excited Molecular Luminescence Imaging in Tissue.

Cherenkov-excited luminescence scanned imaging (CELSI) is achieved with external beam radiotherapy to map out molecular luminescence intensity or lifetime in tissue. Just as in fluorescence microscopy, the choice of excitation geometry can affect the imaging time, spatial resolution and contrast recovered. In this study, the use of spatially patterned illumination was systematically studied comparing scan shapes, starting with line scan and block patterns and increasing from single beams to multiple parallel beams and then to clinically used treatment plans for radiation therapy. The image recovery was improved by a spatial-temporal modulation-demodulation method, which used the ability to capture simultaneous images of the excitation Cherenkov beam shape to deconvolve the CELSI images. Experimental studies used the multi-leaf collimator on a clinical linear accelerator (LINAC) to create the scanning patterns, and image resolution and contrast recovery were tested at different depths of tissue phantom material. As hypothesized, the smallest illumination squares achieved optimal resolution, but at the cost of lower signal and slower imaging time. Having larger excitation blocks provided superior signal but at the cost of increased radiation dose and lower resolution. Increasing the scan beams to multiple block patterns improved the performance in terms of image fidelity, lower radiation dose and faster acquisition. The spatial resolution was mostly dependent upon pixel area with an optimized side length near 38mm and a beam scan pitch of P = 0.33, and the achievable imaging depth was increased from 14mm to 18mm with sufficient resolving power for 1mm sized test objects. As a proof-of-concept, in-vivo tumor mouse imaging was performed to show 3D rendering and quantification of tissue pO2 with values of 5.6mmHg in a tumor and 77mmHg in normal tissue

Optical and X-Ray Technology Synergies Enabling Diagnostic and Therapeutic Applications in Medicine

X-ray and optical technologies are the two central pillars for human imaging and therapy. The strengths of x-rays are deep tissue penetration, effective cytotoxicity, and the ability to image with robust projection and computed-tomography methods. The major limitations of x-ray use are the lack of molecular specificity and the carcinogenic risk. In comparison, optical interactions with tissue are strongly scatter dominated, leading to limited tissue penetration, making imaging and therapy largely restricted to superficial or endoscopically directed tissues. However, optical photon energies are comparable with molecular energy levels, thereby providing the strength of intrinsic molecular specificity. Additionally, optical technologies are highly advanced and diversified, being ubiquitously used throughout medicine as the single largest technology sector. Both have dominant spatial localization value, achieved with optical surface scanning or x-ray internal visualization, where one often is used with the other. Therapeutic delivery can also be enhanced by their synergy, where radio-optical and optical-radio interactions can inform about dose or amplify the clinical therapeutic value. An emerging trend is the integration of nanoparticles to serve as molecular intermediates or energy transducers for imaging and therapy, requiring careful design for the interaction either by scintillation or Cherenkov light, and the nanoscale design is impacted by the choices of optical interaction mechanism. The enhancement of optical molecular sensing or sensitization of tissue using x-rays as the energy source is an important emerging field combining x-ray tissue penetration in radiation oncology with the molecular specificity and packaging of optical probes or molecular localization. The ways in which x-rays can enable optical procedures, or optics can enable x-ray procedures, provide a range of new opportunities in both diagnostic and therapeutic medicine. Taken together, these two technologies form the basis for the vast majority of diagnostics and therapeutics in use in clinical medicine

Review of biomedical Čerenkov luminescence imaging applications

Abstract: Čerenkov radiation is a fascinating optical signal, which has been exploited for unique diagnostic biological sensing and imaging, with significantly expanded use just in the last half decade. Čerenkov Luminescence Imaging (CLI) has desirable capabilities for niche applications, using specially designed measurement systems that report on radiation distributions, radiotracer and nanoparticle concentrations, and are directly applied to procedures such as medicine assessment, endoscopy, surgery, quality assurance and dosimetry. When compared to the other imaging tools such as PET and SPECT, CLI can have the key advantage of lower cost, higher throughput and lower imaging time. CLI can also provide imaging and dosimetry information from both radioisotopes and linear accelerator irradiation. The relatively short range of optical photon transport in tissue means that direct Čerenkov luminescence imaging is restricted to small animals or near surface human use. Use of Čerenkov-excitation for additional molecular probes, is now emerging as a key tool for biosensing or radiosensitization. This review evaluates these new improvements in CLI for both medical value and biological insigh

The Effective Dose of Different Scanning Protocols Using the Sirona Galileos® Comfort CBCT Scanner

Introduction: Cone Beam CT imaging is prevalent in dentistry yet much is unknown with regard to how radiation dose to the patient varies between different CBCT scanners and imaging protocols. Scanner and protocol specific effective dose calculations will aid in optimizing individualized protocols for clinical applications. Purpose: To determine the effective dose for a range of imaging protocols using the Sirona GALILEOS Comfort CBCT scanner. Materials and Methods: Calibrated InLight nanoDot OSL dosimeters (Landauer, Glenwood, Ill) were placed at 26 select sites in the head and neck of a modified, human tissue-equivalent RANDO phantom. Effective dose was calculated using the measured local absorbed doses, accounting for the fractional volume and type of tissue exposed, and applying the 2007 ICRP1 tissue weighting factors. In total, 12 different scanning protocols were investigated varying the field of view, mAs, contrast and resolution parameters. Results: The effective doses for a repeated protocol (full maxillomandibular scan, maximum (42) mAs, high contrast and resolution) were 140, 141 and 142 µSv. This compares to 100 µSv for a maxillary scan and 107 µSv for a mandibular scan with identical mAs, contrast and resolution settings. Effective dose remained between 140-142 µSv for maxillomandibular scans at 42 mAs with varying contrast and resolution settings. Conclusions: Changes to mAs and beam collimation have a significant influence on effective dose. Effective dose varies linearly with mAs. Collimating to obtain a narrower maxillary or mandibular scan decreases effective dose by approximately 28% and 23% respectively as compared to a full maxillomandibular scan. Changes to contrast and resolution settings have little influence on effective dose. This study provides data for setting individualized patient exposure protocols in order to minimize patient dose from ionizing radiation used for diagnostic or treatment planning tasks in dentistry